心力衰竭患者的血压管理
本文为叙述性综述,总结心衰患者血压治疗的现有证据。指南推荐射血分数降低的心衰合并高血压患者使用有心衰适应症的药物,目标血压130/80 mmHg;射血分数保留的心衰治疗策略尚不明确,建议参照前者。低血压不应阻碍改善预后药物的上调,需特殊关注老年、糖尿病、慢性肾病和房颤患者。
要点
- HFrEF合并高血压:用有心衰适应症的药物,目标血压130/80 mmHg。
- HFpEF:最佳策略不明确,指南建议参照HFrEF治疗策略。
- 低血压不应阻碍改善预后药物上调,只要患者耐受。
核心结论
- 心衰患者血压与临床结局的关系及降压的重要性尚不明确。
- HFrEF合并高血压指南共识推荐使用有心衰适应症的药物,目标血压130/80 mmHg。
- HFpEF最佳治疗策略不明确,指南建议采用与HFrEF相似的治疗策略。
- 低血压不应阻碍改善预后药物的上调,前提是患者耐受且无不良事件。
研究设计与样本
- 叙述性综述,总结心衰患者血压治疗的现有证据并指出关键研究问题。
主要发现
- 多数改善心衰预后的药物具有降低血压的潜力。
- 基线血压可能不影响治疗疗效与安全性,最低血压患者可能获得更高绝对风险降低。
关键数值与推荐
- HFrEF合并高血压:目标血压130/80 mmHg,使用有心衰适应症的药物。
- HFpEF:指南承认最佳治疗策略不明确,推荐采用与HFrEF相似的治疗策略。
临床怎么用
- HFrEF合并高血压按指南目标130/80 mmHg治疗,选用有心衰适应症的药物。
- 低血压不应妨碍改善预后药物的上调,只要患者耐受。
- 老年、糖尿病、慢性肾病和房颤患者需特殊考虑和调整治疗。
局限性
- 心衰患者血压与结局关系及降压重要性尚不明确。
- HFpEF最佳治疗策略不明确。
- 需要更多心衰患者血压管理的证据,多病共存增加治疗复杂性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hypertension is a common comorbidity in patients with heart failure and most drugs that have demonstrated to improve prognosis in this population have the potential to reduce blood pressure. Nonetheless, the relationship between blood pressure and clinical outcomes and the relevance of blood pressure reduction in heart failure remains unclear. This narrative review summarises the evidence currently available to guide blood pressure treatment in this patient group and highlights key questions for further research. In patients with heart failure with reduced ejection fraction, guidelines consensually recommend treating hypertension with drugs that have compelling indications in heart failure, with a target blood pressure of 130/80 mmHg. In patients with heart failure with preserved ejection fraction, guidelines acknowledge that the optimal treatment strategy remains unclear and thus recommend adopting a similar treatment strategy to patients with reduced ejection fraction. In any case, low blood pressure should not deter uptitration of drugs otherwise indicated to improve prognosis in heart failure, provided that patients tolerate drugs without adverse events. In the absence of evidence for modification of treatment efficacy and safety by baseline blood pressure, it is likely that treatment may actually lead to higher absolute risk reduction in patients with the lowest blood pressure. Special considerations and treatment adjustments are needed in the elderly as well as in patients with diabetes, chronic kidney disease and atrial fibrillation. More evidence is needed on blood pressure management in patients with heart failure in general, in whom the increasing burden of multimorbidity adds further complexity to treatment.
引用
- Pinho-Gomes AC, Rahimi K. Management of blood pressure in heart failure. Heart. 2019. PMID: 30674544. doi:10.1136/heartjnl-2018-314438
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。